Catheter Stabilization Devices Market - By Product, By Application, By End Use - Global Forecast, 2025 - 2034

Catheter Stabilization Devices Market Size

The global catheter stabilization devices market was valued at USD 1.6 billion in 2024 and is projected to exhibit 7% CAGR from 2025 to 2034. Catheter stabilization devices are specialized medical tools designed to securely attach different types of catheters to a patient's body. These devices play a crucial role in minimizing movement, lowering the chances of accidental dislodgement, and preventing catheter migration, all of which contribute to patient safety and the effective delivery of treatment.
 

The global rise in chronic conditions, such as cardiovascular diseases, cancer, diabetes, and end-stage kidney failure, has significantly increased the use of catheters in healthcare settings. According to the World Health Organization (WHO) 2024 report, cardiovascular diseases were the leading cause of non-communicable disease (NCD) deaths in 2021, accounting for approximately 19 million fatalities.
 

This was followed by cancer with 10 million deaths, chronic respiratory diseases with 4 million deaths, and diabetes, including kidney disease-related deaths caused by diabetes, contributing to over 2 million fatalities. This growing prevalence of chronic diseases is driving the demand for catheter stabilization devices, which are essential for reducing complications, ensuring catheter security, and improving safety during extended hospital stays or frequent outpatient treatments.
 

The aging population is increasingly susceptible to chronic diseases, leading to a higher demand for invasive medical interventions such as IV therapy, urinary catheterization, and dialysis. This demographic also experiences more fragile skin, necessitating enhanced stabilization of catheter devices to ensure safety and comfort during treatment. Consequently, the market for high-quality catheter stabilization devices is witnessing significant growth, particularly among elderly individuals requiring home care services.
 

Hospitals are increasingly focusing on reducing catheter-associated infections, including CLABSIs and CAUTIs, as part of their infection control strategies. Catheter stabilization devices play a critical role in minimizing catheter migration and preventing the entry of microbes or foreign matter into the intraluminal space by reducing unnecessary catheter manipulation. Growing awareness among healthcare providers and hospitals about the benefits of these devices has led to their integration into standard infection prevention protocols, driving a positive growth trend in the market.
 

Catheter Stabilization Devices Market Trends

• Healthcare facilities are increasingly transitioning from traditional measures such as sutures and tape to new and improved catheter stabilization devices. These newer devices provide the same catheter stabilization benefits while decreasing the risk of infection, decreasing skin irritation to the patient, and improving overall patient comfort.
   
• Hospitals are adopting catheter stabilization as a standard practice, and health systems are making investment decisions based on improved clinical results and lower long-term costs associated with complications or device dislodgment.
   
• Manufacturers are incorporating antimicrobial agents and hypoallergenic materials into catheter stabilization devices to mitigate the risk of infections and to improve patient comfort.
   
• This trend results partially due to best practices and more stringent infection control protocols, and the need to accommodate sensitive or aging skin, especially in long term care and geriatric settings where skin integrity is an ongoing challenge.
   
• As healthcare moves toward continuing care in the home, ambulatory infusion services and related vendors aim to meet the need for reliable, extremely easy-to-apply, and long-tenured securement device solutions. These products allow patients with chronic illness to safely manage venous access devices at home while preventing hospital readmissions and creating efficiency from care organizations.
   

Catheter Stabilization Devices Market Analysis

Based on product, the market is segmented into arterial securement devices, central venous catheter securement devices, peripheral securement devices, urinary catheters securement devices, chest drainage tubes securement devices, and other products. The central venous catheter securement devices segment dominated the market with the largest revenue share of 32.7% in 2024.
 

• Central venous catheters (CVCs) are extensively utilized in intensive care units (ICUs), emergency departments, and oncology units for the safe administration of medications, parenteral nutrition, and chemotherapeutics.
   
• The rising demand for critical and cancer care globally is expected to drive the market for securement devices designed to prevent catheter dislodgement, reduce bloodstream infection risks, and ensure uninterrupted care. According to the American Cancer Society, approximately 20 million new cancer cases were reported in 2022.
   
• CVCs are associated with a high risk of bloodstream infections, including insertion site infections, septic thrombophlebitis, endocarditis, metastatic infections, and bacteremia, which can lead to severe clinical outcomes, including mortality. Consequently, hospitals and regulatory authorities have implemented stringent infection prevention guidelines, mandating the use of securement devices. These measures are significantly contributing to the revenue growth of this segment.
   

Based on application, the catheter stabilization devices market is segmented into cardiovascular procedures, general surgery, urological procedures, oncology procedures, and other applications. The general surgery segment dominated the market with the largest revenue of USD 553.5 million in 2024 and is also expected to grow at a significant CAGR over the forecast period.
 

• Catheters, including central venous, urinary, arterial, and peripheral line catheters, play a critical role in general surgeries for fluid management, anesthesia delivery, and patient monitoring. Securement devices are widely utilized during these procedures to ensure catheter stability throughout the operation and recovery phases, particularly during patient transfers between operating rooms, recovery units, and wards. This extensive application in surgical settings drives significant demand for securement devices.
   
• Hospitals are prioritizing efforts to reduce central line-associated bloodstream infections (CLABSIs), and surgical site infections (SSIs) that may increasingly occur during general surgeries. Studies indicate that catheter stabilization minimizes micro-movements, which can reduce the risk of introducing bacteria at the insertion site, thereby reducing infection risks.
   
• In general surgeries, where maintaining aseptic conditions is critical, securement devices have become an integral component of medical protocols, such as surgical safety checklists, and are increasingly incorporated into infection prevention strategies.

Based on end use, the catheter stabilization devices market is segmented into hospitals, ambulatory surgical centers, home care settings, and other end users. The hospitals segment dominated the market with the largest revenue share of 53.9% in 2024.
 

• Hospitals are intensifying efforts to mitigate catheter-associated infections (CAUTIs and CLABSIs), which are often caused by catheter dislodgement and insufficient stabilization. According to an April 2025 study by the National Center for Biotechnology Information, CAUTIs account for approximately 35% of all hospital-acquired infections (HAIs) globally.
   
• Securement devices are essential in infection prevention as they limit catheter movement, protect insertion sites, and block microbial entry. Their integration into hospital infection control protocols has driven consistent demand across acute care settings.
   
• In addition, guidelines from organizations such as the CDC, WHO, and the Joint Commission are emphasizing on the use of non-suture catheter securement devices to enhance patient outcomes and reduce hospital-acquired complications. Hospitals are increasingly adopting these recommendations to comply with standards and avoid penalties, further driving demand for securement devices across various catheter applications.

The North America catheter stabilization devices market was valued at USD 731.5 million in 2024 and is expected to grow at a CAGR of 6.9% over the forecast period. The market is driven by the presence of stringent infection control protocols across healthcare settings and increasing aging population across the region.
 

The U.S. market is projected to grow significantly from USD 667.5 million in 2024 to USD 1.3 billion by 2034.
 

• Increasing growth in chronic diseases including cardiovascular diseases is driving the demand for catheter-based treatments across healthcare settings in the U.S. According to the June 2022 study published by Cochrane Library, about 275,000 to 300,000 cardiac surgical procedures were performed annually in the U.S. during the study period, 2012-2022. As a result, the demand for catheters is increasing across the country, which is further driving the demand for catheter stabilization devices.
   
• Hospitals in the U.S. are governed by regulatory bodies such as the Centers for Medicare & Medicaid Services (CMS), the Centers for Disease Control and Prevention (CDC), and the Joint Commission. These agencies mandate adherence to clinical and safety standards, including the implementation of evidence-based infection prevention protocols, that promotes the use of catheter securement devices in the U.S.
   
• Failure to reduce catheter-associated infection rates can result in regulatory penalties and decreased reimbursement rates. This has driven hospitals to adopt catheter securement devices to ensure compliance with regulatory requirements in the U.S.
   
• The U.S. healthcare system is increasingly focused on enhancing patient-centered outcomes while minimizing costs. Catheter securement devices help hospitals prevent costly complications, such as line dislodgement and hospital-acquired infections, thereby improving operational efficiency.
   
• With the rise of value-based reimbursement models, such as the Hospital-Acquired Condition Reduction Program, U.S. hospitals are prioritizing investments in catheter securement devices. These devices support efforts to lower readmission rates and deliver cost-effective, high-quality care.
   

Europe catheter stabilization devices market was valued at USD 412.4 million in 2024 and is expected to grow at a CAGR of 6.7% over the forecast period.
 

• European healthcare systems prioritize the prevention of hospital-acquired infections (HAIs) and combating antimicrobial resistance. Organizations such as the European Centre for Disease Prevention and Control (ECDC) have issued recommendations for catheter insertion and maintenance protocols (ECDC 2023).
   
• Healthcare systems across Europe are increasingly adopting securement devices to mitigate the risks of catheter-associated infections. With well-established public health and infection surveillance systems, there is significant potential to enhance the adoption of securement devices in the region.
   
• Most European healthcare systems operate under publicly funded or universal healthcare models, where cost efficiency and equitable care delivery are key priorities.
   
• The adoption of securement devices has demonstrated their effectiveness in reducing complications, facilitating earlier patient discharge, and aligning with outcome-based healthcare delivery models. Countries such as Germany, France, UK, and the Nordics are integrating these devices into clinical guidelines and procurement policies to improve healthcare outcomes and efficiency. This is aiding to the revenue growth of the market in Europe.
   

The catheter stabilization devices market in UK is expected to experience significant and promising growth from 2025 to 2034.
 

• The NHS has implemented targeted measures to reduce catheter-associated infections, including CAUTIs and CLABSIs. Guidelines from organizations such as the National Institute for Health and Care Excellence (NICE) emphasize the use of non-suture catheter securement methods to prevent these infections. This has led to increased adoption of securement devices across NHS trusts and hospitals in the UK, which is fuelling the market growth.
   
• The UK government has invested around USD 2 billion to set up surgical hubs, with the goal of boosting surgical capacity by adding more than 100 operating theatres and 1,000 hospital beds. This initiative is expected to enable nearly 2 million extra routine surgeries over 2022-2025, breaking down to 200,000 additional procedures in 2022–2023, 700,000 in 2023–2024, and expected 1 million by the end of 2025.
   
• With this surge in surgical procedures, UK is witnessing a growing need for catheter stabilization devices, which are crucial for ensuring effective perioperative care and reducing the risk of infections.
   

The Asia Pacific catheter stabilization devices market is expected to grow at the fastest CAGR of 7.7% over the forecast period.
 

• China, India, Indonesia, and Vietnam are heavily investing in the expansion of hospitals, intensive care units (ICUs), and surgical centers. The implementation of modern clinical protocols in these facilities is driving the demand for catheter securement devices. As per Invest India’s Investment Grid, approximately 600 investment opportunities valued at USD 32 billion exist within India’s hospital and medical infrastructure sub-sector.
   
• The rising number of surgical procedures, critical care admissions, and catheter-based therapies is significantly increasing the demand for securement devices, which are now considered essential for enhancing patient safety and reducing complications.
   
• The Asia-Pacific (APAC) region is positioning itself as a global hub for medical tourism, particularly for surgical, oncology, and fertility treatments, as well as other medical conditions that require dependable catheter usage during treatment.
   
• Hospitals across the region are focusing on meeting international clinical standards to minimize post-operative complications and infections. This has resulted in a growing preference for advanced catheter securement devices that enhance patient outcomes and provide greater comfort during both short- and long-term hospital stays.
   

Japan catheter stabilization devices market is anticipated to witness lucrative growth between 2025 – 2034.
 

• Japan with its significantly high elderly population (30% of total population aged 65 and above in 2023, as per World Bank Group), is experiencing rise in chronic disease such as cancer, cardiovascular disease, and renal failure. All of these diseases frequently require devices that involve long term usage of catheters, whether for prosthetic medication delivery, or for dialysis or drainage. As a result, the demand for catheter stabilization devices is increasing in the country.
   
• Additionally, as there is both a growing elderly population in Japan, as well as fragile skin in this population; there is an increasing demand for advanced, reliable, and skin-friendly catheter securement devices such as securement devices incorporating antimicrobial agents and hypoallergenic materials. These devices are priced higher in comparison to standard catheter securement devices, which contributes to the overall revenue growth.
   
• In addition, the Japanese Ministry of Health, Labour, and Welfare regulates the country through stringent infection control measures, which focuses on the use of advanced catheter stabilization devices to prevent hospital acquired infections. Such initiatives and policy measures further drives the demand for catheter stabilization devices in Japan.
   

Brazil catheter stabilization devices market is anticipated to witness lucrative growth between 2025 – 2034.
 

• Brazil is significantly investing in enhancing healthcare infrastructure, including hospitals (both public and private), operating rooms, Intensive Care Units (ICUs), and ambulatory care facilities. For instance, in October 2024, Federal Government allocates USD 840million to boost the health industry and meet the needs of the SUS. These advancements are driving the demand for advanced devices across healthcare facilities such as advanced catheter securement devices to ensure patient safety and reduce complications during treatment or hospital stays.
   
• In addition, rising prevalence of chronic conditions such as diabetes, cancer, and renal diseases in Brazil is further increasing the need for long-term catheterization for treatments like chemotherapy, dialysis, and fluid management.
   
• As a result, there is growing demand for securement devices with lower failure rates to prevent catheter dislodgement and infections, particularly in outpatient and home care settings, which is contributing to the revenue growth of the market in the country.
   

Middle East and Africa: The Saudi Arabia catheter stabilization devices market is expected to experience significant and promising growth from 2025 to 2034.
 

• Saudi Arabia is significantly investing in expanding and modernizing its healthcare system as part of Vision 2030. New hospitals, specialized medical facilities, and ICU's, along with recent hospital renovations are expected to increase catheter-based procedures, further driving the demand for catheter securement devices.
   
• Additionally, the patient population is experiencing increasing pressure and burden from chronic conditions such as diabetes, heart and vascular diseases, and cancers requiring multiple catheterizations for long treatment periods for healthcare concerns like dialysis and chemotherapy. According to a study published in the Elsevier Journal in February 2025, 23% of Saudi Arabia's population was diabetic, with heart disease and obesity also being prevalent health concerns.
   
• The pressure to invest in consumer-friendly, reliable, and durable catheter securement devices will continue to grow, as chronic care leads to an increasing desire to minimize complications and enhance patient comfort. Such factors are expected to significantly boost market growth in the country over the forecast period.
   

Catheter Stabilization Devices Market Share

The market is characterized by a competitive landscape comprising both international and domestic players offering innovative solutions to address the increasing demand for advanced devices among a growing patient population. Key players such as 3M, BD, B. Braun, ConvaTec, and Cardinal Health collectively hold approximately 65% of the market share. The competition is driven by ongoing technological advancements and the ability to deliver customized solutions.
 

In developing countries, where cost considerations are a priority, multinational companies face pressure to provide catheter stabilization devices that are both affordable and high-quality. Domestic manufacturers capitalize on this demand by offering cost-effective alternatives, prompting multinational firms to adjust their pricing strategies while ensuring product safety, durability, and compliance with regulatory standards.
 

Catheter Stabilization Devices Market Companies

Some of the eminent market participants operating in the catheter stabilization devices industry include:

• B. Braun
• Baxter International
• Becton, Dickinson and Company
• Cardinal Health
• Centurion Medical Products
• ConvaTec
• Dale Medical Products
• DeRoyal Industries
• Merit Medical Systems
• Pepper Medical
• Smiths Medical
• TIDI Products
• VYGON
• Zibo Qichuang Medical Products
• 3M
   
• 3M holds a significant share of the catheter securement market, driven by its Tegaderm and Steri-Strip product lines. These advanced silicone adhesive securement solutions ensure secure fixation while minimizing the risk of skin irritation and medical adhesive-related skin injury (MARSI). Additionally, these products support infection control as they are compatible with IV dressings and surgical drapes.
   
• Becton, Dickinson and Company has capitalized on its comprehensive vascular access portfolio by integrating Nexiva IV catheters with high-performance securement solutions. These products address clinical challenges such as device dislodgement, which occurs in approximately 40% of vascular access devices, and complications like phlebitis. Becton, Dickinson and Company's suture less stabilization products, such as BD Pegasus, offer infection risk reduction compared to traditional sutures.
   
• B. Braun is a prominent player in the securement solutions market, recognized for its Fixomull product line and other offerings designed to reduce hospital-acquired infections (HAIs), particularly in long-term catheterization cases (e.g., PICCs, CVCs). The company's porous and hypoallergenic adhesives minimize skin damage, while its suture less solutions lower the risk of bacterial colonization. B. Braun also emphasizes ergonomic designs and patient comfort, making its products suitable for both pediatric and geriatric care.
   

Catheter Stabilization Devices Industry News:

• In January 2025, B. Braun, one of the key player in smart infusion therapy and pain management, announced the launch of Clik-FIX Epidural/Peripheral Nerve Block (PNB) Catheter Securement Device. This new addition to the Clik-FIX Family of Catheter Securement Devices is designed to be soft, low-profile, and secure, helping to minimize the chances of catheter displacement and dislodgement during regional anesthesia procedures.
   
• In January 2025, Becton, Dickinson and Company announced to expand its investments in the U.S. manufacturing sector. This move aims to expand production capacity for essential medical devices like syringes, needles, and intra-venous catheters, ensuring that the U.S. healthcare system can continue to meet its ongoing demands.
   
• In September 2023, Interrad Medical, a company based in the US, announced a partnership with Vygon UK to distribute its catheter securement device, SecurAcath, throughout England, Scotland, and Wales. The latest addition to their product lineup is the 9Fr option, which is available exclusively through Vygon. This new size is designed for use with larger multi-lumen CVC lines.
   
• In September 2022, B. Braun announced that it has acquired the Clik-Fix catheter securement device portfolio from Starboard Medical. This move enhances their lineup of peripheral intravenous (IV) therapy devices. By integrating the innovative Clik-Fix portfolio with B. Braun's expertise and commercial strengths, the company aims to adapt to their customers’ changing needs and solidify their role in the IV therapy market.
   

The catheter stabilization devices market research report includes an in-depth coverage of the industry with estimates and forecast in terms of revenue in USD million from 2021 – 2034 for the following segments:

Click here to Buy Section of this Report

By Product

• Arterial securement devices
• Central venous catheter securement devices
• Peripheral securement devices
• Urinary catheters securement devices
• Chest drainage tubes securement devices
• Other products

By Application

• Cardiovascular procedures
• General surgery
• Urological procedures
• Oncology procedures
• Other applications

By End Use

• Hospitals
• Ambulatory surgical centers
• Home care settings
• Other end use

The above information is provided for the following regions and countries:

• North America 
  • U.S.
  • Canada 
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Netherlands 
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea 
• Latin America
  • Brazil
  • Mexico
  • Argentina 
• Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE